NHI250117P115000
- 0.00
- 0.000.00%
National Health Investors Inc Newsroom
Wedbush Cuts Price Target on National Health Investors to $77 From $87, Keeps Outperform Rating
National Health Investors Price Target Lowered to $66 From $77 at Jefferies
National Health Investors Inc To Go Ex-Dividend On December 31st, 2024 With 0.9 USD Dividend Per Share
National Health Investors Price Target Cut to $72.00/Share From $78.00 by Truist Securities
National Health Investors Analyst Ratings
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Monday as Investors Assess Fed's Interest Rate Outlook
Truist Financial Maintains National Health Investors Inc(NHI.US) With Hold Rating, Announces Target Price $72
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Hold Rating, Announces Target Price $76
Top 3 Real Estate Stocks Which Could Rescue Your Portfolio In Q4
CHCT or NHI: Which Is the Better Value Stock Right Now?
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Hold Rating
BofA Securities Maintains National Health Investors Inc(NHI.US) With Buy Rating, Cuts Target Price to $91
Express News | National Health Investors Inc : Jefferies Raises Target Price to $77 From $76
Navigating Risks: National Health Investors' Potential Exposure in Forward Sale Agreements
Earnings Call: National Health Investors Reports Mixed Q3 Results Amid Growth
National Health Investors, Inc. (NHI) Q3 2024 Earnings Call Transcript Summary
Truist Financial Maintains National Health Investors Inc(NHI.US) With Hold Rating
Wells Fargo Initiates National Health Investors Inc(NHI.US) With Hold Rating, Announces Target Price $86
Analysts Offer Insights on Real Estate Companies: National Health Investors (NHI) and Peakstone Realty Trust (PKST)
Hold Rating Maintained for National Health Investors Amid Financial Uncertainty and Strategic Challenges